SoftBank leads $1.2 billion investment in diagnostics firm Invitae

This post was originally published on this site

https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEH340I1_L.jpg

(Reuters) – A group of investors including SoftBank Group Corp will invest $1.15 billion in Invitae (NYSE:NVTA) Corp, the U.S. genetic diagnostics company said on Monday.